跳至主要内容
临床试验/NCT04627480
NCT04627480进行中(未招募)4 期

Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial

ProofPilot1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
ProofPilot
入组人数
200
试验地点
1
主要终点
Change in total sleep per night at week 4 between active and sham arm

研究概览

简要总结

Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device (CES) for the treatment of insomnia characterized by difficulties with sleep maintenance using a 20-minute treatment right before bedtime.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Sham Device

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than or equal to 21 US resident Can receive packages to their home via UPS/Fedex/USPS Read/write English Insomnia Severity Index Score Greater than 14 Diagnosis of insomnia by a medical physician Subjects with a Generalized Anxiety Diagnosis will be excluded Have not contemplated suicide in the past year Not been institutionalized for mental health issues. Not currently being treated for or suspect a mental health issue Not currently experiencing problems with alcohol or drug abuse Can commit to not drinking alcohol 4 hours before bedtime for the duration of the study Not taking medications affecting the nervous system (e.g. psychiatric medications) Not taking hypnotics or any sleep aid or marijuana (in any form) Can commit to one (1) 20 minute session per day for 8 weeks Has not used a brain stimulation treatment in one year No suspected or known history of heart disease No pacemaker, or any form of medical electronics, including but not limited to a deep brain stimulator, electronic stent, etc.
  • Not under medical supervision for other serious medical condition Not taking opioids No pain or headaches that interrupt sleep Not participating in any other sleep study Not experiencing restless leg syndrome No Nickel Allergy No Sleep Apena as measured by STOP-Bang Assessment

排除标准

  • 未提供

结局指标

主要结局

Change in total sleep per night at week 4 between active and sham arm

时间窗: baseline versus week 4

Measured by Fitbit Charge 4 connected health device work on the wrist

次要结局

  • Change in Insomnia Severity between Sham versus active arms(baseline versus week 4)
  • Change in WASO (wake after sleep onset) between sham versus active arms(baseline versus week 4)
  • Device Tolerance and Safety measured by SAFTEE(4 weeks from baseline)

研究者

发起方
ProofPilot
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of a Neurostimulation Device for... | 临床试验